PF-Atlas › Clinical Trials › NCT04888715

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

DWN12088 · Phase 1

Registry ID
NCT04888715
Phase
Phase 1
Status
Completed
Drug / intervention
DWN12088
Sponsor
Daewoong Pharmaceutical Co. LTD.
Start
2021-07-23
Enrollment
48
Locations
1

About this trial

An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and Pirfenidone or Nintedanib in healthy volunteers

View NCT04888715 on ClinicalTrials.gov →

Explore related

All DWN12088 trialsAll IPF trials

Related trials

DWN12088 — NCT05389215DWN12088 — NCT04888728
Medical disclaimer. This page summarizes public trial data for NCT04888715 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.